A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years

被引：20
|
作者：
Mateos, Maria-Victoria
Oriol, Albert [2 ]
Martinez, Joaquin [3 ]
Teresa Cibeira, Ma [4 ]
Gutierrez, Norma C. [1 ]
Jose Terol, Maria [5 ]
de Paz, Raquel [6 ]
Garcia-Larana, Jose [7 ]
Bengoechea, Enrique
Martin Garcia-Sancho, Alejandro [8 ]
Martinez, Rafael [9 ]
Palomera, Luis [10 ]
de Arriba, Felipe [11 ]
Gonzalez, Yolanda [12 ]
Hernandez, Jose [13 ]
Sureda, Anna [14 ]
Bello, Jose-Luis [15 ]
Jose Lahuerta, Juan [16 ]
Blade, Joan [17 ]
San-Miguel, Jesus F. [18 ]
机构：
[1] CSIC, USAL, IBMCC, Hosp Univ Salamanca,CIC, Salamanca, Spain
[2] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[3] Hosp Doce Octubre, Madrid, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Hosp Clin Univ Valencia, Barcelona, Spain
[6] Hosp Univ La Paz, Madrid, Spain
[7] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[8] Hosp Virgen Concha, Zamora, Spain
[9] Hosp Clin San Carlos, Madrid, Spain
[10] Hosp Lozano Blesa, Zaragoza, Spain
[11] Hosp Morales Meseguer, Murcia, Spain
[12] Hosp Josep Trueta, Girona, Spain
[13] Hosp Gen Segovia, Segovia, Spain
[14] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[15] Hosp Clin Univ Santiago Compostela, Santiago De Compostela, Spain
[16] Hosp 12 Octubre, E-28041 Madrid, Spain
[17] IDIBAPS, Hosp Clin, Barcelona, Spain
[18] Hosp Clin Univ Salamanca, Salamanca, Spain
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.3.3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
    Gasparetto, C
    Keogh, GP
    Gockerman, JP
    Horwitz, M
    Moore, JO
    DeCastro, C
    Diehl, L
    Davis, P
    Chao, N
    Rizzieri, DA
    [J]. BLOOD, 2005, 106 (11) : 379B - 379B
  • [32] Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Asian Patients with Newly Diagnosed Multiple Myeloma: Final Analysis of the Phase 3 Octans Study
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Carson, Robin
    Liu, Rui
    Wang, Lingling
    Zhao, Man
    Chen, Xi
    Cui, Canchan
    Hou, Jian
    Wang, Jianxiang
    [J]. BLOOD, 2023, 142
  • [33] RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY OF SILTUXIMAB (AN ANTI-IL-6 MAB) AND BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS BORTEZOMIB-MELPHALAN-PREDNISONE IN PATIENTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA
    San Miguel, J.
    Blade, J.
    Samoilova, O.
    Shpilberg, O.
    Grosicki, S.
    Maloisel, F.
    Min, C.
    Zarzuela, M.
    Robak, T.
    Khuageva, N.
    Prasad, S.
    Goh, Y.
    Laubach, J.
    Spencer, A.
    Mateos, M.
    Palumbo, A.
    van de Velde, H.
    Uhlar, C.
    Qin, X.
    Xie, H.
    Orlowski, R.
    [J]. HAEMATOLOGICA, 2013, 98 : 97 - 97
  • [34] Factors predictive of outcome in relapsed, refractory multiple myeloma patients treated with bortezomib, melphalan, prednisone, and thalidomide (VMPT)
    Palumbo, A. P.
    Ambrosini, M. T.
    Benevolo, G.
    Pescosta, N.
    Callea, V.
    Cangialosi, C.
    Caravita, T.
    Morabito, F.
    Gay, F.
    Boccadoro, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Pharmacogenomic (PGx) Analysis of Bortezomib-Associated Peripheral Neuropathy in the Phase 3 VISTA Trial of Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Multiple Myeloma
    Ricci, Deborah S.
    Favis, Reyna
    Sun, Yu
    van de Velde, Helgi
    Broderick, Erin
    Meyers, Michael
    Harousseau, Jean-Luc
    Avet-Loiseau, Herve
    Richardson, Paul G.
    San Miguel, Jesus F.
    [J]. BLOOD, 2009, 114 (22) : 1491 - 1491
  • [36] Comparative Efficacy and Safety of Daratumumab in Combination with Bortezomib, Melphalan, and Prednisone (D-VMP) in Alcyone Versus Bortezomib, Melphalan, and Prednisone (VMP) in Vista in Newly Diagnosed Multiple Myeloma (NDMM) Patients Using Propensity Score Matching (PSM)
    Cavo, Michele
    Dimopoulos, Meletios A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Jakubowiak, Andrzej
    Deraedt, William
    Lam, Annette
    Kampfenkel, Tobias
    Qi, Ming
    He, Jianming
    [J]. BLOOD, 2018, 132
  • [37] Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study
    Mateos, Maria-Victoria
    San-Miguel, Jesus
    Cavo, Michele
    Creixenti, Joan Blade
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Pei, Huiling
    Krevvata, Maria
    Carson, Robin
    Borgsten, Fredrik
    Dimopoulos, Meletios A.
    [J]. BLOOD, 2022, 140 : 10157 - 10159
  • [38] BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Kim, M. K.
    Kim, K.
    Yoon, D. H.
    Suh, C.
    Moon, J. H.
    Lee, Y. J.
    Lee, J. H.
    Jung, S. -H.
    Kim, H. J.
    Bae, S. H.
    Kim, J. S.
    Lee, J. -O.
    Eom, H. S.
    Lee, W. -S.
    Kang, H. J.
    Mun, Y. -C.
    Do, Y. R.
    Hyun, M. S.
    [J]. HAEMATOLOGICA, 2017, 102 : 793 - 793
  • [39] A prospective randomized controlled trial of oral melphalan, prednisone, thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients
    Palumbo, A.
    Aitoro, G.
    Bringhen, S.
    Caravita, T.
    Callea, V.
    Zambello, R.
    Pregno, P.
    Carubelli, A.
    Baraldi, A.
    Cellini, C.
    Dore, F.
    Piro, E.
    Ambrosini, M. T.
    Musto, P.
    Liberati, A. M.
    Boccadoro, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII161 - VII161
  • [40] Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:: results of a multicenter phase 1/2 study
    Mateos, Maria-Victoria
    Hernandez, Jose-M.
    Hernandez, Miguel-T
    Gutierrez, Norma-C.
    Palomera, Luis
    Fuertes, Marta
    Diaz-Mediavilla, Joaquin
    Lahuerta, Juan-J.
    de la Rubia, Javier
    Terol, Maria-Jose
    Sureda, Ana
    Bargay, Joan
    Ribas, Paz
    de Arriba, Felipe
    Alegre, Adrian
    Oriol, Albert
    Carrera, Dolores
    Garcia-Larana, Jos
    Garcia-Sanz, Ramon
    Blade, Joan
    Prosper, Felipe
    Mateo, Gemma
    Esseltine, Dixie-Lee
    de Velde, Helgi van
    San Miguel, Jesus-F.
    [J]. BLOOD, 2006, 108 (07) : 2165 - 2172
12345